Clinical Trials
3
Active:2
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Phase 2
Completed
- Conditions
- Hematologic MalignanciesAcute Myeloid LeukemiaLymphoid LeukemiaChronic Myeloid LeukemiaHodgkin's DiseaseNon-Hodgkin's LymphomaMyelodysplastic Syndromes
- Interventions
- Drug: StemEx®
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2015-07-10
- Lead Sponsor
- Gamida Cell -Teva Joint Venture Ltd.
- Target Recruit Count
- 101
- Registration Number
- NCT00469729
- Locations
- 🇺🇸
UCLA's Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
🇺🇸The Children's Hospital, B115, University of Colorado Health Sciences Center, Aurora, Colorado, United States
News
No news found